Long-Term Impact of Endoscopic Gallbladder Stenting for Calculous Cholecystitis in Poor Surgical Candidates: A

Tadahisa Inoue1, Yuta Suzuki2, Michihiro Yoshida3

  • 1Department of Gastroenterology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan. tinoue-tag@umin.ac.jp.

Insights

Endoscopic gallbladder stenting (EGBS) helps prevent cholecystitis recurrence in high-risk patients but has a lower success rate. Prolonged stent use increases the risk of other adverse events.

Area of Science:

  • Gastroenterology
  • Minimally Invasive Surgery
  • Biliary Tract Interventions

Background:

  • Acute calculous cholecystitis poses risks for high-risk surgical candidates.
  • Endoscopic gallbladder stenting (EGBS) is an alternative to surgery, but its long-term outcomes are not well-established.
  • Percutaneous transhepatic gallbladder drainage (PTGBD) is another drainage option for these patients.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of EGBS compared to PTGBD in patients unfit for cholecystectomy.
  • To assess recurrence rates of cholecystitis and the incidence of adverse events associated with each procedure.

Main Methods:

  • A comparative study involving 528 high-risk surgical patients with acute calculous cholecystitis.
  • Patients were treated with either EGBS or PTGBD.
  • Technical success, early adverse events, and long-term outcomes including cholecystitis recurrence and late adverse events were compared.

Main Results:

  • EGBS had a significantly lower technical success rate (75.4%) than PTGBD (98.7%).
  • Early adverse event rates were similar between EGBS (7.7%) and PTGBD (4.3%).
  • EGBS showed significantly lower rates of cholecystitis recurrence (7.2% at 5 years) compared to PTGBD (30.2% at 5 years), but higher rates of other symptomatic late adverse events (31.4% at 5 years vs. 13.1% for PTGBD).

Conclusions:

  • Long-term EGBS is effective in preventing cholecystitis recurrence in patients unsuitable for surgery.
  • However, EGBS is associated with a lower technical success rate and an increased frequency of other late adverse events with prolonged indwelling times.
Abstract